Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
14.23
+0.22 (1.57%)
At close: Jul 17, 2026, 4:00 PM EDT
16.00
+1.77 (12.44%)
After-hours: Jul 17, 2026, 7:35 PM EDT
Contineum Therapeutics Employees
Contineum Therapeutics had 51 employees as of December 31, 2025. The number of employees increased by 10 or 24.39% compared to the previous year.
Employees
51
Change (1Y)
10
Growth (1Y)
24.39%
Revenue / Employee
n/a
Profits / Employee
-$1,145,961
Market Cap
532.01M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 51 | 10 | 24.39% |
| Dec 31, 2024 | 41 | 10 | 32.26% |
| Dec 31, 2023 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Arvinas | 246 |
| ProKidney | 231 |
| Ocugen | 116 |
| Silence Therapeutics | 88 |
| Assembly Biosciences | 73 |
| Rezolute | 68 |
| Altimmune | 57 |
| Crescent Biopharma | 55 |
CTNM News
- 17 days ago - Contineum publishes manuscript on PIPE-791 in Journal of Medicinal Chemistry - TheFly
- 17 days ago - Contineum Therapeutics Publishes Discovery of Potential Best-in-Class LPAR1 Antagonist PIPE-791 in Journal of Medicinal Chemistry - Business Wire
- 5 weeks ago - Contineum Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Contineum Therapeutics to Present at the 2026 Goldman Sachs Global Healthcare Conference - Business Wire
- 2 months ago - Contineum Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Contineum price target raised to $16 from $14 at Morgan Stanley - TheFly
- 2 months ago - Contineum Therapeutics to Present at the 2026 RBC Capital Markets Global Healthcare Conference - Business Wire